CE vs TERN
Celanese Corporation (CE) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CE currently screens at market cap $5.92B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CE and TERN stock pages for the full models.
Not investment advice.